PTCT PTC Therapeutics Inc

USD 29.09 -0.35 -1.188859
Icon

PTC Therapeutics Inc (PTCT) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 29.09

-0.35 (-1.19)%

USD 2.23B

1.08M

USD 30.80(+5.88%)

USD 0.00 (-100.00%)

Icon

PTCT

PTC Therapeutics Inc (USD)
COMMON STOCK | NSD
USD 29.09
0.00 0
Take a Tour
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 2.23B

USD 0.00 (-100.00%)

USD 29.09

PTC Therapeutics Inc (PTCT) Stock Forecast

Show ratings and price targets of :
USD 30.80
(+5.88%)

Based on the PTC Therapeutics Inc stock forecast from 8 analysts, the average analyst target price for PTC Therapeutics Inc is USD 30.80 over the next 12 months. PTC Therapeutics Inc’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of PTC Therapeutics Inc is Slightly Bearish, which is based on 3 positive signals and 4 negative signals. At the last closing, PTC Therapeutics Inc’s stock price was USD 29.09. PTC Therapeutics Inc’s stock price has changed by -3.58% over the past week, +3.16% over the past month and -35.53% over the last year.

No recent analyst target price found for PTC Therapeutics Inc
No recent average analyst rating found for PTC Therapeutics Inc

Company Overview PTC Therapeutics Inc

PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders in the United States and internationally. The company offers Translarna and Emflaza for the treatment of Duchenne muscula...Read More

https://www.ptcbio.com

100 Corporate Court, South Plainfield, NJ, United States, 07080

988

December

USD

USA

Adjusted Closing Price for PTC Therapeutics Inc (PTCT)

Loading...

Unadjusted Closing Price for PTC Therapeutics Inc (PTCT)

Loading...

Share Trading Volume for PTC Therapeutics Inc Shares

Loading...

Compare Performance of PTC Therapeutics Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for PTCT

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To PTC Therapeutics Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
NVO
Novo Nordisk A/S +0.35 (+0.27%) USD554.45B 46.01 4.80

ETFs Containing PTCT

Symbol Name PTCT's Weight Expense Ratio Price(Change) Market Cap
IBRN
iShares Trust - iShares N.. 4.14 % 0.47 % +0.01 (+0.06%) USD3.86M

Frequently Asked Questions About PTC Therapeutics Inc (PTCT) Stock

Based on ratings from 8 analysts PTC Therapeutics Inc's stock is Buy . Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 3 buy, 1 sell and 6 hold ratings.

Unfortunately we do not have enough data on PTCT's stock to indicate if its a good dividend stock.

Based on targets from 8 analysts, the average taret price for PTCT is USD 30.80 over the next 12 months. The maximum analyst target price is USD 51 while the minimum anlayst target price is USD 17.

Unfortunately we do not have enough data on PTCT's stock to indicate if its overvalued.

The last closing price of PTCT's stock was USD 29.09.

The most recent market capitalization for PTCT is USD 2.23B.

Based on targets from 8 analysts, the average taret price for PTCT is projected at USD 30.80 over the next 12 months. This means that PTCT's stock price may go up by +5.88% over the next 12 months.

Following are ETFs with the highest allocation to PTC Therapeutics Inc's stock :

IBRN

As per our most recent records PTC Therapeutics Inc has 988 Employees.

PTC Therapeutics Inc's registered address is 100 Corporate Court, South Plainfield, NJ, United States, 07080. You can get more information about it from PTC Therapeutics Inc's website at https://www.ptcbio.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...